Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease
Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T et al.. Archives of neurology, 2000-11-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Objective To determine whether the cystatin C gene (CST3) is genetically associated with late-onset Alzheimer disease (AD). Design A case-control study with 2 independent study populations of patients with AD and age-matched, cognitively normal control subjects. Setting The Alzheimer's Disease Research Unit at the University Hospital Hamburg-Eppendorf, Hamburg, Germany, for the initial study (n = 260). For the independent multicenter study (n = 647), an international consortium that included the Massachusetts Alzheimer's Disease Research Center at the Massachusetts General Hospital, Boston; the Scientific Institute for Research and Patient Care, Brescia, Italy; and Alzheimer's research units at the Universities of Basel and Zurich, Switzerland, and Bonn, Goettingen, and Hamburg, Germany. Participants Five hundred seventeen patients with AD and 390 control subjects. Measures Molecular testing of the KspI polymorphisms in the 5' flanking region and exon 1 of CST3 and the apolipoprotein E (APOE) genotype. Mini-Mental State Examination scores for both patients with AD and control subjects. Results Homozygosity for haplotype B of CST3 was significantly associated with late-onset AD in both study populations, with an odds ratio of 3.8 (95% confidence interval, 1.56-9.25) in the combined data set; heterozygosity was not associated with an increased risk. The odds ratios for CST3 B/B increased from 2.6 in those younger than 75 years to 8.8 for those aged 75 years and older. The association of CST3 B/B with AD was independent of APOE epsilon4; both genotypes independently reduced disease-free survival. Conclusions CST3 is a susceptibility gene for late-onset AD, especially in patients aged 75 years and older. To our knowledge, CST3 B is the first autosomal recessive risk allele in late-onset AD.
What this study adds
Evidence grade: Moderate
This is a case-control study of 260 participants. In a case-control study of 517 Alzheimer's patients and 390 controls, homozygosity for haplotype B of the cystatin C gene was significantly associated with late-onset Alzheimer's disease, with an odds ratio of 3.8. This suggests a genetic association, but no treatment or prevention is tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Finckh, U., von der Kammer, H., Velden, J., Michel, T., Andresen, B., Deng, A., et al. (2000). Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Archives of neurology. https://doi.org/10.1001/archneur.57.11.1579
Vancouver
Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, et al. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Archives of neurology. 2000. doi:10.1001/archneur.57.11.1579. PMID: 11074789.
BibTeX
@article{finckh2000-11074789,
author = {Finckh, U. and von der Kammer, H. and Velden, J. and Michel, T. and Andresen, B. and Deng, A. and Zhang, J. and Müller-Thomsen, T. and others},
title = {{Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease}},
journal = {Archives of neurology},
year = {2000},
doi = {10.1001/archneur.57.11.1579},
pmid = {11074789},
url = {https://doi.org/10.1001/archneur.57.11.1579}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Objective To determine whether the cystatin C gene (CST3) is genetically associated with late-onset Alzheimer disease (AD).
- Results Homozygosity for haplotype B of CST3 was significantly associated with late-onset AD in both study populations, with an odds ratio of 3.8 (95% confidence interval, 1.56-9.25) in the combined data set; heterozygosity was not associated with an increased risk.
Why it matters
In a case-control study of 517 Alzheimer's patients and 390 controls, homozygosity for haplotype B of the cystatin C gene was significantly associated with late-onset Alzheimer's disease, with an odds ratio of 3.8. This suggests a genetic association, but no treatment or prevention is tested.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcase-control study
- Participants260
- Evidence strengthModerate
How this study scored 55/100
Published in a peer-reviewed journal, and it is a case-control study. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2000 — older than 20 years, still counted |
| Sample size | 2 / 4 | 260 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 140 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.0 citations a year over 28 year(s) since 2000 |
| Impact for its field and year | 3 / 6 | Cited 4.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 3 other studies in this library |
| Still being cited | 1 / 4 | Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Ulrich Finckh: h-index 35 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Zurich: institution h-index 1,220 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | PubMed indexes it as a multicentre study |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 11074789) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
3 studies in the alzhub library list this one in their references.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.